Loading...
No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration
BACKGROUND: Although ranibizumab has been used for the treatment of wet age-related macular degeneration (AMD) since 2007, real-world studies still report undertreatment resulting in a less favorable visual outcome. In this study, two different time cohorts of patients treated with ranibizumab for w...
Na minha lista:
| Udgivet i: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5472435/ https://ncbi.nlm.nih.gov/pubmed/28652696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S130182 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|